We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Feedback Plc | LSE:FDBK | London | Ordinary Share | GB00BJN59X09 | ORD 50P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 97.50 | 95.00 | 100.00 | 97.50 | 97.50 | 97.50 | 5,188 | 07:36:53 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Electronic Computers | 1.03M | -2.92M | -0.2188 | -4.46 | 13M |
Date | Subject | Author | Discuss |
---|---|---|---|
16/6/2021 12:17 | When Penine take Bleepa, the product will sell itself. Things, could indeed, get very exciting. | ducatiman | |
16/6/2021 12:03 | Regional rollout will do for me. If that happened I would expect 100% effort into trusts and the UK - no divided world conquering efforts. There must be enough private and other possible users for such a small company like fdbk to get a decent grounding in the UK. If its necessary to go off around the world, then its a niche product, with a much smaller market than expected. | yump | |
16/6/2021 11:56 | I do believe we are nearing the signing of the Pennine contract and it will likely be a watershed moment as far as the market is concerned. It is quite simple really and I am assuming everything is working very efficiently with Bleepa or else why roll out to others. Shares look oversold to me. | petekand | |
16/6/2021 11:43 | Correct Ged | ducatiman | |
16/6/2021 10:50 | Well spotted Pete. Had a quick look to see there was no RNS then fell back asleep. (Late night playing on-line chess!) I think you've answered the question, Ducatiman. This must be the start of the regional roll-out trial. "The Trust wants to broaden the use of Bleepa as part of its strategy for greater collaboration and communication amongst clinical staff." The Trust wants! Maybe they are planning to roll-out across the region. | ged5 | |
16/6/2021 05:27 | Yes, good find Pete, why no RNS? Free? | ducatiman | |
15/6/2021 22:17 | Nice find Pete, that'll put a smile on Ged's face. | lr2 | |
15/6/2021 16:53 | Yes, apart from 3 trades I'd say all buys. One of those sells was for £2.85! Only matched by a buy for £2.99. I've seen such small trades a lot elsewhere recently but don't understand why they're made. | ged5 | |
15/6/2021 16:45 | Lot of buying today. I guess nobody agrees with Trevor's pithy putdowns regarding Bleepa. | lr2 | |
15/6/2021 16:38 | Don't we all, LR2, don't we all? £12k worth bought late on paying .99p. And a smaller buy at .987p. Let's hope that continues tomorrow. | ged5 | |
15/6/2021 16:25 | Had a quick look this AM and anything higher than 0.94p were buys. You won't hear much from me this week as I'm not at home and typing on a very old and erratic tablet. I wish Feedback would do a DIS and go up 250%. | lr2 | |
15/6/2021 14:14 | I agree news is needed. I tried to buy some DIS that LR2 recommended a while ago. News out and I couldn't buy any. The same happens here. We've all seen this move very quickly and it's difficult to buy. Anyway I had a small top up here. The 1m isn't mine though. | ged5 | |
15/6/2021 13:47 | News badly needed, simple as. | ducatiman | |
15/6/2021 13:19 | Always the best time to sell when the share price and the RSI are at their lowest and buy when it's at its highest. ;))) I presume everything above .905 is a buy. | ged5 | |
15/6/2021 10:15 | Have I missed anything here. Are they still struggling to give bleepr away? | lukehold | |
14/6/2021 18:35 | I do wish they would send, whoever posts for them on Twitter, on an English language course. SP not looking good Tom, hope there is still a lot going on and that we should still be watching this space. | ducatiman | |
13/6/2021 21:42 | The internet didn’t need broadband - it was functioning ok. And yet broadband appeared. Faster and faster. Daft and diverting argument from ydder that because something is functioning, it can’t be improved. This board is no way a cult or echo chamber. Thats just a ridiculous assertion based on nothing. About as “ad hominem” as you can get. | yump | |
13/6/2021 12:26 | I've never been a fan of those anonymous posters who try to protect my interests. I like many on this thread have done the research and have paid for shares they can afford. If it comes off then we'll be rewarded. It's taking time but it's moving in the right direction. Not the share price yet but the work that's going on. There's only one competitor that I know of that in any way resembles Bleepa that we haven't discussed. That's in the US and it's expensive. They haven't shown any signs to my knowledge of expanding into Europe. You go on about your question not being answered yet if you look back to posts on this thread it has. You seem to have plenty of time on your hands so go and look. The cheek of you! You haven't answered any of the questions I asked you. As far as I am concerned you're just making noise. I'd prefer the reality:- | ged5 | |
13/6/2021 11:56 | ydderF - taken from website " Bleepa is a new way of delivering care, connecting teams flexibly over distance and equipping them with the information they need to make informed clinical decisions. Bleepa is a secure instant messaging system that shares clinical-grade medical images on devices such as a phone, tablet, or desktop with an internet connection. Bleepa connects to all DICOM compliant radiology and cardiology imaging systems (such as MRI, CT, X-ray, angiogram, ultrasound)" They mention "tablet" not iPad but as the app is available for iPhones I reckon it will work on iPads too. Also works on desktops so what was the point of your 3rd paragraph trying to denigrate it's usage and giving an impression it's for small screens only? | digger2779 | |
12/6/2021 13:46 | Yes indeed Ged, it could, get very exciting. Here’s hoping. | ducatiman | |
12/6/2021 13:22 | thanx ducatiman // Ged5 ! - i think i am enjoying the "new region-wide approach" cheers . | leoboy | |
12/6/2021 13:16 | LR2 Yes. Someone trying to appear clever by using Occam’s razor but in the wrong context, is not worthy of more words. Especially when not debating a point they first made and then just diverting onto another one. I’d like to see the comparison between Bleepa’s features and competitor features, seeing as competitors were raised as an objection. | yump |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions